Theralase Technologies Financials
| TLTFF Stock | USD 0.14 0.01 7.69% |
With this module, you can analyze Theralase financials for your investing period. You should be able to track the changes in Theralase Technologies individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Theralase |
The data published in Theralase Technologies' official financial statements typically reflect Theralase Technologies' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Theralase Technologies' quantitative information. For example, before you start analyzing numbers published by Theralase accountants, it's essential to understand Theralase Technologies' liquidity, profitability, and earnings quality within the context of the Health Care Equipment & Supplies space in which it operates.
Theralase Technologies Stock Summary
Theralase Technologies competes with Biomerica, Semler Scientific, NanoVibronix, Abbott Laboratories, and Stryker. Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. Theralase Technologies Inc. was founded in 1994 and is based in Toronto, Canada. Theralase Technologi operates under Medical Devices classification in the United States and is traded on OTC Exchange.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | CA88337V1004 |
| Business Address | 41 Hollinger Road, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.theralase.com |
| Phone | 416 699 5273 |
| Currency | USD - US Dollar |
Theralase Technologies Key Financial Ratios
There are many critical financial ratios that Theralase Technologies' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Theralase Technologies reports annually and quarterly.| Return On Equity | -1.13 | |||
| Return On Asset | -0.59 | |||
| Number Of Employees | 12 | |||
| Beta | 1.92 | |||
| Z Score | 74.4 |
Theralase Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Theralase Technologies's current stock value. Our valuation model uses many indicators to compare Theralase Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Theralase Technologies competition to find correlations between indicators driving Theralase Technologies's intrinsic value. More Info.Theralase Technologies is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Theralase Technologies' earnings, one of the primary drivers of an investment's value.Theralase Technologies Systematic Risk
Theralase Technologies' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Theralase Technologies volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Theralase Technologies correlated with the market. If Beta is less than 0 Theralase Technologies generally moves in the opposite direction as compared to the market. If Theralase Technologies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Theralase Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Theralase Technologies is generally in the same direction as the market. If Beta > 1 Theralase Technologies moves generally in the same direction as, but more than the movement of the benchmark.
Theralase Technologies March 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Theralase Technologies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Theralase Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Theralase Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Theralase OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Theralase Technologies's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 26.76 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 7.69 |
Complementary Tools for Theralase OTC Stock analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance |